Vanguard Capital Wealth Advisors’s Nautilus Biotechnolgy NAUT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.6K | Hold |
16,000
| – | – | 0.01% | 114 |
|
|
2025
Q1 | $13.8K | Sell |
16,000
-15,500
| -49% | -$13.3K | 0.02% | 111 |
|
|
2024
Q4 | $52.9K | Sell |
31,500
-3,500
| -10% | -$5.88K | 0.06% | 110 |
|
|
2024
Q3 | $99.8K | Hold |
35,000
| – | – | 0.1% | 107 |
|
|
2024
Q2 | $81.9K | Sell |
35,000
-1,500
| -4% | -$3.51K | 0.06% | 132 |
|
|
2024
Q1 | $107K | Sell |
36,500
-3,500
| -9% | -$10.3K | 0.08% | 140 |
|
|
2023
Q4 | $120K | Sell |
40,000
-6,000
| -13% | -$17.9K | 0.1% | 131 |
|
|
2023
Q3 | $145K | Sell |
46,000
-13,000
| -22% | -$41.1K | 0.13% | 116 |
|
|
2023
Q2 | $228K | Sell |
59,000
-16,500
| -22% | -$63.9K | 0.21% | 104 |
|
|
2023
Q1 | $209K | Buy |
75,500
+52,500
| +228% | +$145K | 0.21% | 104 |
|
|
2022
Q4 | $41.4K | Buy |
23,000
+500
| +2% | +$900 | 0.05% | 117 |
|
|
2022
Q3 | $48K | Sell |
22,500
-1,700
| -7% | -$3.63K | 0.06% | 108 |
|
|
2022
Q2 | $65K | Sell |
24,200
-2,500
| -9% | -$6.72K | 0.07% | 121 |
|
|
2022
Q1 | $115K | Sell |
26,700
-18,800
| -41% | -$81K | 0.08% | 144 |
|
|
2021
Q4 | $235K | Buy |
+45,500
| New | +$235K | 0.17% | 116 |
|